CLIMB BIO, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
CLIMB BIO, INC. (CLYM) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 26.24 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-16
- CLIMB BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 26.24M shares, a 659.23% increase year-over-year.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 26.38M shares, a 731.60% increase year-over-year.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 15.59M shares, a 736.20% increase year-over-year.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 3.49M shares, a 87.56% increase year-over-year.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 12.26M shares, a 460.40% increase from fiscal 2020.
- CLIMB BIO, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 2.19M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 26.24M shares 10-Q · filed 2022-05-16 | 26.31M shares derived: average of 2 quarters · filed 2022-05-16 | 22.73M shares derived: average of 3 quarters · filed 2022-05-16 | 17.92M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | 26.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | 20.98M shares derived: average of 2 quarters · filed 2022-03-07 | 15.15M shares derived: average of 3 quarters · filed 2022-03-07 | 12.26M shares 10-K · filed 2022-03-07 |
| 2021-09-30 | 15.59M shares 10-Q · filed 2021-11-08 | 9.54M shares derived: average of 2 quarters · filed 2021-11-08 | 7.55M shares 10-Q · filed 2021-11-08 | 6.43M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2021-06-30 | 3.49M shares 10-Q · filed 2021-09-13 | 3.47M shares 10-Q · filed 2021-09-13 | 3.37M shares derived: average of 3 quarters · filed 2022-05-16 | 2.99M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2021-03-31 | 3.46M shares 10-Q · filed 2022-05-16 | 3.31M shares derived: average of 2 quarters · filed 2022-05-16 | 2.83M shares derived: average of 3 quarters · filed 2022-05-16 | 2.59M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | 3.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | 2.52M shares derived: average of 2 quarters · filed 2022-03-07 | 2.30M shares derived: average of 3 quarters · filed 2022-03-07 | 2.19M shares 10-K · filed 2022-03-07 |
| 2020-09-30 | 1.86M shares 10-Q · filed 2021-11-08 | 1.86M shares derived: average of 2 quarters · filed 2021-11-08 | 1.86M shares 10-Q · filed 2021-11-08 | |
| 2020-06-30 | 1.86M shares 10-Q · filed 2021-09-13 | 1.86M shares 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |